nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0691	0.332	CbGbCtD
Desvenlafaxine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0642	0.308	CbGbCtD
Desvenlafaxine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0295	0.142	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.027	0.13	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0184	0.0885	CbGbCtD
Desvenlafaxine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.0141	0.705	CrCbGaD
Desvenlafaxine—Venlafaxine—ABCB1—peripheral nervous system neoplasm	0.00591	0.295	CrCbGaD
Desvenlafaxine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00133	0.00172	CcSEcCtD
Desvenlafaxine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00132	0.00171	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00132	0.00171	CcSEcCtD
Desvenlafaxine—Chills—Etoposide—peripheral nervous system neoplasm	0.00131	0.0017	CcSEcCtD
Desvenlafaxine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00131	0.0017	CcSEcCtD
Desvenlafaxine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00169	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00169	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0013	0.00169	CcSEcCtD
Desvenlafaxine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00169	CcSEcCtD
Desvenlafaxine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00168	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00167	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00167	CcSEcCtD
Desvenlafaxine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00167	CcSEcCtD
Desvenlafaxine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00129	0.00167	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00167	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00128	0.00165	CcSEcCtD
Desvenlafaxine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00127	0.00164	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00164	CcSEcCtD
Desvenlafaxine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00163	CcSEcCtD
Desvenlafaxine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00163	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00126	0.00163	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00163	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00162	CcSEcCtD
Desvenlafaxine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00125	0.00161	CcSEcCtD
Desvenlafaxine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00124	0.00161	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00124	0.0016	CcSEcCtD
Desvenlafaxine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.0016	CcSEcCtD
Desvenlafaxine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00121	0.00157	CcSEcCtD
Desvenlafaxine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00156	CcSEcCtD
Desvenlafaxine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00156	CcSEcCtD
Desvenlafaxine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0012	0.00156	CcSEcCtD
Desvenlafaxine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.00156	CcSEcCtD
Desvenlafaxine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00155	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00154	CcSEcCtD
Desvenlafaxine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00118	0.00154	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00153	CcSEcCtD
Desvenlafaxine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00153	CcSEcCtD
Desvenlafaxine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00153	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00152	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00152	CcSEcCtD
Desvenlafaxine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00117	0.00152	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.0015	CcSEcCtD
Desvenlafaxine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00116	0.0015	CcSEcCtD
Desvenlafaxine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.0015	CcSEcCtD
Desvenlafaxine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00116	0.0015	CcSEcCtD
Desvenlafaxine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.0015	CcSEcCtD
Desvenlafaxine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00115	0.00149	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00149	CcSEcCtD
Desvenlafaxine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00149	CcSEcCtD
Desvenlafaxine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00114	0.00148	CcSEcCtD
Desvenlafaxine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00147	CcSEcCtD
Desvenlafaxine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00112	0.00146	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00112	0.00145	CcSEcCtD
Desvenlafaxine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00145	CcSEcCtD
Desvenlafaxine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00145	CcSEcCtD
Desvenlafaxine—Rash—Topotecan—peripheral nervous system neoplasm	0.00111	0.00144	CcSEcCtD
Desvenlafaxine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00111	0.00144	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00111	0.00144	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00144	CcSEcCtD
Desvenlafaxine—Headache—Topotecan—peripheral nervous system neoplasm	0.00111	0.00144	CcSEcCtD
Desvenlafaxine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00143	CcSEcCtD
Desvenlafaxine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0011	0.00143	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.0011	0.00143	CcSEcCtD
Desvenlafaxine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.0011	0.00143	CcSEcCtD
Desvenlafaxine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00143	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Headache—Tretinoin—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Constipation—Vincristine—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00142	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00142	CcSEcCtD
Desvenlafaxine—Rash—Melphalan—peripheral nervous system neoplasm	0.00109	0.00141	CcSEcCtD
Desvenlafaxine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00109	0.00141	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00108	0.0014	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00108	0.00139	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00139	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00138	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00106	0.00137	CcSEcCtD
Desvenlafaxine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00105	0.00136	CcSEcCtD
Desvenlafaxine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00135	CcSEcCtD
Desvenlafaxine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00135	CcSEcCtD
Desvenlafaxine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00133	CcSEcCtD
Desvenlafaxine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00103	0.00133	CcSEcCtD
Desvenlafaxine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00132	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00101	0.00131	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00131	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00101	0.00131	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.001	0.0013	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.001	0.0013	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.00128	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000986	0.00128	CcSEcCtD
Desvenlafaxine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000985	0.00128	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000981	0.00127	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000979	0.00127	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000978	0.00127	CcSEcCtD
Desvenlafaxine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000954	0.00124	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000944	0.00122	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000934	0.00121	CcSEcCtD
Desvenlafaxine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000932	0.00121	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000931	0.00121	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000925	0.0012	CcSEcCtD
Desvenlafaxine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000923	0.0012	CcSEcCtD
Desvenlafaxine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000919	0.00119	CcSEcCtD
Desvenlafaxine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000912	0.00118	CcSEcCtD
Desvenlafaxine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00091	0.00118	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000904	0.00117	CcSEcCtD
Desvenlafaxine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000904	0.00117	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000902	0.00117	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000896	0.00116	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000895	0.00116	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000887	0.00115	CcSEcCtD
Desvenlafaxine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000879	0.00114	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000877	0.00114	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000864	0.00112	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000861	0.00112	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.00086	0.00111	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000856	0.00111	CcSEcCtD
Desvenlafaxine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000852	0.0011	CcSEcCtD
Desvenlafaxine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000847	0.0011	CcSEcCtD
Desvenlafaxine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000845	0.0011	CcSEcCtD
Desvenlafaxine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000838	0.00109	CcSEcCtD
Desvenlafaxine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000837	0.00109	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000837	0.00108	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000835	0.00108	CcSEcCtD
Desvenlafaxine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000833	0.00108	CcSEcCtD
Desvenlafaxine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000815	0.00106	CcSEcCtD
Desvenlafaxine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000813	0.00105	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000809	0.00105	CcSEcCtD
Desvenlafaxine—Rash—Vincristine—peripheral nervous system neoplasm	0.000808	0.00105	CcSEcCtD
Desvenlafaxine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000807	0.00105	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000805	0.00104	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000803	0.00104	CcSEcCtD
Desvenlafaxine—Headache—Vincristine—peripheral nervous system neoplasm	0.000803	0.00104	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.00103	CcSEcCtD
Desvenlafaxine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.00102	CcSEcCtD
Desvenlafaxine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000775	0.001	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000774	0.001	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000992	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000765	0.000991	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000989	CcSEcCtD
Desvenlafaxine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000761	0.000986	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00076	0.000985	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000748	0.00097	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000745	0.000965	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.000965	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000963	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000962	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00074	0.000958	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000738	0.000956	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000735	0.000952	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000938	CcSEcCtD
Desvenlafaxine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00072	0.000933	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000717	0.00093	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.000928	CcSEcCtD
Desvenlafaxine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000714	0.000926	CcSEcCtD
Desvenlafaxine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000714	0.000925	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000713	0.000924	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00071	0.00092	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000917	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000915	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.000911	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000906	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000904	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000692	0.000897	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000891	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000686	0.000889	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.000887	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000885	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00068	0.000881	CcSEcCtD
Desvenlafaxine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000673	0.000872	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000672	0.00087	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000868	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.00086	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00066	0.000855	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.000855	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—peripheral nervous system neoplasm	0.000654	0.000848	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000654	0.000847	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—peripheral nervous system neoplasm	0.00065	0.000842	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000839	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000837	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.00083	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00064	0.00083	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000828	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00063	0.000816	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000812	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000805	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000618	0.0008	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000616	0.000799	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000615	0.000797	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000784	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000603	0.000781	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000769	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000768	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000766	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000755	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000751	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000742	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.00074	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00057	0.000739	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000569	0.000738	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000736	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000732	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000729	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.000725	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000723	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000712	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000686	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.000684	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000682	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000681	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000677	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000677	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000674	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000517	0.00067	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000655	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000651	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000502	0.00065	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000645	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000631	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000626	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.00062	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000606	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000602	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000601	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000596	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000555	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000541	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000516	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000514	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.0005	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000498	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000479	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000477	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000475	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000475	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000472	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000461	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000448	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000443	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00044	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000439	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000437	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000414	CcSEcCtD
